
Gilead (GILD) Stock Rises 0.68% in Pre-Market as Japan Set to Approve Remdesivir Today
Gilead (GILD) stock price is rising slightly after the Japanese government indicated that it could grant approval to its remdesivir drug to be used in the fight with COVID-19.